reviewed by certified public auditor as follows: Overall performance results of the Company for the three-month period ended 31 March 2019, compared to the same period of the previous year were as

by certified public auditor as follows: Overall performance results of the Company for the six-month period ended 30 June 2019, compared to the same period of the previous year were as highlighted

previous year were as highlighted below; Separate financial statements (Unit : Million Baht) Q2/2019 Q2/2018 % Change 6 Month 2019 6 Month 2018 % Change Sales and Service Income 516 467 10 1,001 934 7 Cost

public auditor as follows: Overall performance results of the Company for the three-month period ended 31 March 2020, compared to the same period of the previous year were highlighted as below; (Unit

/2020 and 2019 respectively, an increase of THB 4.6 MB compared to the same period of the previous year, mainly from promotion programs and staff expenses. For the financial cost which increased amount

percent (35.5 percent in Q1/2019). The company has maintained the gross margin as same as the previous year.  Sales Expenses Q1/2020, the Company and its subsidiaries had the expenses of 21.2 MB, decreased

, an increase of 813.6 million baht or 9.9 percent from the previous year, with the proportion of general patient revenue accounting for 64.4 percent, 34.3 percent from the Social Security patients, and

TS1 and Gulf TS2 in this quarter, adding our Equity MW under operation to 447.1 MW from 319.3 MW in the same period of last year. • Financial costs decreased by 35.3%, mainly from loan repayment from

second quarter of 2017, Gulf TS1 and Gulf TS2 in the third quarter of 2017 and Gulf TS3 in the last quarter of this year, adding our Equity MW under operation, at the end of 2017, to 478.4 MW from 349.6 as

Equity (7.27) 5.29 (12.56) (237.43%) (4.86) (2.41) 49.59% (18.46) 10.26 (28.72) (279.92%) - Non-controlling Interest 0.34 (0.56) 0.90 (160.71%) 0.22 0.12 54.55% 0.58 (0.54) 1.12 (207.41%) For 9-month